Optical Cross-Sectional Muscle Area Determination of Drosophila Melanogaster Adult Indirect Flight Muscles
March 31st, 2018
We report a method to quantify muscle area, which is an indirect method to determine muscle mass in Drosophila adults. We demonstrate the application of our methodology by analyzing the indirect flight muscles in a Drosophila model of Myotonic Dystrophy disease.
The overall goal of this procedure is to quantify the muscle area in the Drosophila adult muscles as a means to indirectly quantify muscle mass and correctly size the generation or muscle atrophy. For this purpose, we focused on dorsal longitudinal muscles because of their size, distribution, and also count on this position, a low and easy orientation for transversal sectioning. One, fixation and resin embedding.
The first step of the procedure is to anesthetize the flies with CO2, and, with the help of scissors and forceps, remove the legs, the wings, and the terminal part of the abdomen. Secondly, carefully transfer the carcasses, to avoid the deformation of the thorax, to a one point five milliliter tube on ice, placing a maximum of six individuals per tube containing 200 microliters of solution one. The carcasses cannot remain in this solution for more than 20 minutes.
Finally, add 200 microliters of solution two and incubate on ice for 30 minutes. After incubation, remove all of the liquid, add 200 microliters of solution two, and incubate the carcasses on ice for one to two hours. The next step is to remove the solution and dehydrate the samples through a graded ethanol series.
Incubate the samples twice in propylene oxide for ten minutes each incubation. Then, replace the propylene oxide with a mixture of 500 microliters resin and 500 microliters propylene oxide and incubate the samples at room temperature overnight. The next day, replace the mixture with 100 percent resin and incubate the samples for four hours.
Afterwards, transfer the carcasses to plastic molds containing new resin, making sure you put one carcass in each well of the mold. With a wooden stick, orient the carcasses in the wells and let the resin polymerase overnight in a pasteur oven at 70 degrees Celsius. To discard the resin, bake it at 70 degrees Celsius for 24 hours, because solid, baked resin is not toxic.
Two, trimming and sectioning of blocks. With the help of razor blades, trim away the resin and form a trapezoidal shape surrounding the carcass to give the appropriate orientation in the microtome. Check in the microscope that the muscles are perfectly oriented.
After this, cut one point five micrometer thick sections with an ultramicrotome, and transfer the sections into water drops over gelatinized slides. Finally, place the slides containing the sections on a heating block at 70 to 80 degrees Celsius until all the water evaporates. Three, staining IFM sections.
Cover the sections with toluidine blue for approximately 30 seconds on the heating block. Then, rinse in several changes of water and leave the slides on a warm plate to evaporate the water. Four, mounting IFM sections.
Taking the slides, put one or two drops of mountant medium on the sections and put on a long coverslip. Five, acquisition of images and quantification of muscle area. Use ImageJ software to select an area containing only the DLMs.
Taking as a control the dimensions of the image of the fly with the biggest muscle area, finerize the images, and delete the areas, or pixels, that do not correspond to the muscles of interest. Quantify the percentage of pixels corresponding to muscle tissue out of total with the command analyze, measurement, and select the option, area fraction. This percentage of area is an estimation of the DLM muscular mass of each fly.
Representative results. We determined that the model flies, which express 250 noncoding CTG repeats throughout the musculature, driven by the myosin heavy chain promoter, MhC Gal four, had a 50 percent reduction of muscle area compared to control flies. In contrast, co expression of muscle blind C and expanded CTG repeats with the same driver strongly suppressed such phenotype and cross sectional muscle area was 70 percent of control flies.
Administration of the Abp1 hexapeptide in the nutritive media similarly suppressed the atrophic phenotype and model flies that had taken the compound showed approximately 60 percent of normal muscle area, instead of 50 percent, that is typical of DF1 flies.Conclusions. The protocol presented here is a useful tool for quantifying the muscle degeneration caused by the onset or progression of a particular disease in a fly model. Finally, this method is also optimized to detect small muscle area differences, or even to quantify the area of different structures such as nephyocytes.
Thank you for watching.
View the full transcript and gain access to thousands of scientific videos
Overview
This study presents a method for quantifying muscle area in Drosophila adults, which serves as an indirect measure of muscle mass. The methodology is applied to analyze the indirect flight muscles in a Drosophila model of Myotonic Dystrophy disease.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Genetics
Background
- Understanding muscle mass is crucial for studying muscle atrophy.
- Drosophila serves as a model organism for genetic studies.
- Myotonic Dystrophy is a genetic disorder affecting muscle function.
- Indirect flight muscles are significant for analysis due to their size and accessibility.
Purpose of Study
- To develop a reliable method for quantifying muscle area.
- To indirectly assess muscle mass in Drosophila adults.
- To apply this methodology in the context of Myotonic Dystrophy research.
Methods Used
- Anesthetizing Drosophila with CO2.
- Removing legs, wings, and abdomen for muscle access.
- Embedding carcasses in resin for sectioning.
- Analyzing dorsal longitudinal muscles for quantification.
Main Results
- Successfully quantified muscle area in the Drosophila model.
- Demonstrated the feasibility of the method for muscle atrophy studies.
- Provided insights into the muscle pathology associated with Myotonic Dystrophy.
- Established a framework for future research on muscle disorders.
Conclusions
- The method offers a valuable tool for assessing muscle mass indirectly.
- It can be applied to various studies involving muscle atrophy.
- Further research can expand on the implications for muscle-related diseases.
Frequently Asked Questions
Executive Industry Relevance
Quantitative assessment of muscle cross-sectional area in Drosophila indirect flight muscles enables robust evaluation of genetic and pharmacological modifiers of muscle atrophy. This workflow supports early-stage target validation and mechanistic de-risking in neuromuscular disease models, providing predictive confidence for portfolio triage. The method's sensitivity to subtle phenotypic changes enhances translational continuity from discovery to preclinical research.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables quantitative interrogation of genetic drivers and suppressors of muscle degeneration.
- Supports functional validation of candidate targets implicated in muscle atrophy pathways.
- Facilitates mechanistic de-risking by distinguishing direct versus indirect effects on muscle mass.
- Provides a platform for hypothesis-driven evaluation of disease-relevant phenotypes.
Screening & Assay Development
- Delivers reproducible, semi-automated quantification of muscle area for compound screening.
- Standardizes image analysis and area measurement using ImageJ for cross-study comparability.
- Enables detection of small phenotypic shifts, supporting high-content screening readiness.
- Prepares validated biological systems for downstream pharmacological evaluation.
Translational & Preclinical Research
- Aligns Drosophila muscle phenotypes with disease-relevant endpoints for translational biomarker development.
- Supports continuity from genetic discovery to preclinical compound testing in neuromuscular disease models.
- Enables risk-adjusted advancement decisions based on quantitative phenotypic rescue.
- Provides predictive value for compound efficacy in modifying disease phenotypes.
Pipeline & Workflow Integration
This method integrates into the discovery-to-preclinical continuum, bridging genetic target validation, compound screening, and translational research in neuromuscular disease pipelines.
- Discovery Biology: Quantifies muscle area to test genetic hypotheses and clarify disease mechanisms.
- Screening: Provides standardized, reproducible readouts for compound efficacy evaluation.
- Analytics: Generates quantitative area measurements and statistical comparisons across experimental groups.
- Translational Research: Links Drosophila phenotypes to preclinical endpoints for biomarker alignment.
- Enterprise Reuse: Offers a reusable, scalable workflow for diverse genetic and pharmacological studies.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in target validation.
- Operational Value: Enhances standardization, reproducibility, and scalability of phenotypic assays.
- Strategic Value: Improves go/no-go decision-making and capital efficiency in early-stage programs.
- Portfolio Impact: Supports risk-adjusted prioritization and advancement of neuromuscular disease assets.
Implementation Considerations
- Requires expertise in Drosophila handling, sectioning, and image analysis.
- Needs access to microtomy, optical microscopy, and digital image processing infrastructure.
- Demands cross-team standardization of sample preparation and quantification protocols.
- Adaptable to other muscle groups or tissue types with protocol optimization.
- Limited to models where muscle cross-sectional area is a relevant endpoint.
